Image

Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

Advancing Strategies to Optimize the PerIopeRativE Management of PostOperative Nausea and Vomiting (ASPIRE-PONV) Trial

Recruiting
3 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this prospective, unblinded, pragmatic and repeated crossover trial is to learn if clinical decision support alerts will impact postoperative nausea and vomiting (PONV) prophylaxis and reduce PONV rates in adult and pediatric patients who have planned surgery with general anesthesia. The main aim is to improve PONV, establishing a scalable Clinical Decision Support (CDS) Tool for personalized PONV prevention.

The primary hypothesis is that, compared with standard care, the Anesthesia Workflow-Driven Clinical Decision Support Tool for Personalized PONV Prevention will be associated with a significant improvement in the rate of appropriate administration of PONV prophylaxis and a significant decrease in the incidence of PONV.

This study will evaluate a new clinical decision support (CDS) tool designed to improve how and when PONV prevention strategies are used. Unlike traditional tools that provide generic, one-time alerts, this new system is integrated into the electronic health record (EHR) and delivers timely, targeted reminders to anesthesia providers at key moments during a patient's surgical care-such as before surgery begins, after anesthesia is given, and before the patient wakes up. These alerts are based on each patient's individual risk for PONV and are intended to support, not replace, clinical judgment. The study will use a crossover design over 12 months, alternating between periods when the tool is active and when it is not. The goal is to determine whether this time-sensitive, workflow-integrated tool can lead to better adherence to best practices and improved patient outcomes.

Eligibility

Pediatric Inclusion Criteria

  • Age ≥ 3 and ≤ 17 years old who have
  • Planned surgery with general anesthesia and
  • One or more risk factors for PONV; (history of motion sickness and/or postoperative nausea and vomiting, non-smoker, female gender) Pediatric Exclusion Criteria
  • Age < 3 or > 17 years old,
  • American Society of Anesthesiologist (ASA) classification of 5 or 6 including organ procurement,
  • Monitored Anesthesia Care cases,
  • Patients transferred directly to the ICU,
  • Procedure types:
    • labor epidurals,
    • radiation oncology,
    • MRI without additional procedures,
    • electroconvulsive therapy,
    • surgery duration < 30 minutes. Adult Inclusion Criteria
  • Age ≥ 18 years
  • Planned surgery with general anesthesia
  • Meet one or more risk factors for PONV (history of motion sickness and/or postoperative nausea and vomiting, non-smoker, female gender) Adult Exclusion Criteria
  • ASA 5 or 6 including organ procurement,
  • Patients transferred directly to the ICU,
  • Procedure types:
    • bronchoscopy only,
    • diagnostic imaging only,
    • electroconvulsive therapy,
    • endoscopy without another procedure,
    • intubation only cases,
    • labor epidurals,
    • transesophageal echocardiography (TEE)/cardioversion,
    • surgery duration < 30 minutes.

Study details
    Postoperative Nausea
    Postoperative Vomiting

NCT07152249

Vanderbilt University Medical Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.